|Fastest Growing Market:||Asia-Pacific|
|Largest Market:||North America|
Need a report that reflects how COVID-19 has impacted this market and its growth?
The global intraocular lens market is projected to register a CAGR of 5.6% during the forecast period.
The COVID-19 pandemic made patients extremely hesitant to seek elective health care, including cataract and reconstructive surgery. The market was negatively affected by the COVID-19 pandemic and the resultant lockdowns placed by several countries. The visits to eye clinics or hospitals reduced drastically, and only emergency procedures were being performed. According to data published by the National Center for Biotechnology Information, 2021, titled "Access to Eye Care During the COVID-19 pandemic", it was observed that patient numbers visiting eye care hospitals fell to a mere 3.5%. As the COVID 19 cases rose, many ophthalmologists temporarily closed their practices as a cautionary measure. In some cases, specialized isolated temporary clinics were opened to manage the critical cases among patients. During the pandemic, patients were more inclined toward telemedicine, which was critical in maintaining access to eye care.
Intraocular lenses (IOLs) are implantable medical devices used for vision correction. The key factors propelling the intraocular lens market include increasing ophthalmic issues, growing cases of cataracts in the diabetic population, and rising adoption of advanced premium IOLs. Many people above the age of 60 years are affected by several kinds of ophthalmic issues, which are chronic and demand eye corrections. Owing to such scenarios, the growth IOLs increased with demand, offering more precise solutions and varied options for physicians for a particular disease. Moreover, reimbursement policies for essential ophthalmic surgeries and a definite regulatory framework are enhancing growth in the market.
According to the National Eye Institute, in 2020, the United States recorded 7.7 million diabetic retinopathy cases and 24 million cataract cases, and they are expected to reach 11.3 million and 38 million, respectively, by 2030. In addition, the American Association of Ophthalmology states that the major cause of visual impairment around the world is reported to be cataracts, and geriatric ocular issues are emerging as prime factors in developing countries. Hence, such an increase in ophthalmic conditions across the world is expected to drive the growth of the IOL market over the forecast period.
Moreover, many companies are launching new products in the market to strengthen their position. For instance, in October 2021, Alcon Inc., a division of Novartis, launched the AcrySof IQ Vivity IOL (Vivity), the first and only presbyopia-correcting intraocular lens (PC-IOL) with wavefront-shaping technology in India.
Other than the adoption rate, there are a few challenges associated with intraocular lenses, like the confusion and errors related to intraocular lenses (IOL) and the incorrect IOL implantation, which restrict their usage. In addition, the increasing costs of IOLs and poor reimbursement coverage are expected to hamper the market growth over the forecast period.
Scope of the Report
As per the scope of the report, an intraocular lens is a lens implanted in the eye as part of a treatment for cataracts or myopia. Several types of intraocular lenses are available in the market to improve vision.
The intraocular lens market is segmented by product (monofocal intraocular lens, accommodative intraocular lens, multifocal intraocular lens, and toric intraocular lens), end user (hospitals, ambulatory centers, and other end users), and geography (North America, Europe, Asia-Pacific, Middle-East and Africa, and South America). The report offers the value (in USD million) for the above segments.
|Monofocal Intraocular Lens|
|Accommodative Intraocular Lens|
|Multifocal Intraocular Lens|
|Toric Intraocular Lens|
|By End User|
|Other End Users|
Key Market Trends
Accommodative IOL Expected to Grow the Fastest over the Forecast Period
Accommodative intraocular lenses are known to accommodate well with post-surgical changes compared to monofocal IOLs. These are preferred by patients suffering from macular degeneration, as they support the eye muscles in focusing on intermediate and distant objects. These lenses are widely used in the treatment of presbyopia and astigmatism. Monofocal intraocular lens is the first choice for many, as it can provide the best image quality after surgery, and thus, they hold the largest market share in terms of percentage. The increasing cases of eye disorders and the increased number of surgeries related to eyes are important factors boosting the segment’s growth.
According to Living Well With Low Vision by Prevent Blindness, 2021, the causes of moderate-to-severe vision impairment in people aged over 50 years are age-related macular degeneration, diabetic retinopathy, inadequate vision correction, glaucoma, and cataract.
According to BrightFocus Foundation, in 2020, 11 million people in the United States had some form of age-related macular degeneration, which is expected to double to nearly 22 million by 2050. An increasing number of people facing these eye problems is a significant factor contributing to the significant growth of the segment.
To understand key trends, Download Sample Report
North America Expected to Continue Market Dominance over the Forecast Period
Within North America, the United States holds the major share of the market and is expected to dominate over the forecast period, owing to an increase in the older population, high adoption of new technologies and products in the healthcare sector, and a surge in demand for better healthcare facilities.
In addition, the increasing prevalence of cataract issues, such as age-related cataracts and congenital cataracts, are anticipated to propel the market’s growth over the forecast period. According to statistics published by NVision Centers, 2022, it was found that about 12 million people aged 40 years and above are suffering from vision impairment in the United States.
According to the National Eye Institute, the number of people in the United States with cataracts is expected to double from 24.4 million in 2020 to about 50 million by 2050.
According to the American Academy of Ophthalmology, in 2021, myopia, an eye focusing disorder, was a significant, prevalent disease that affected an estimated 25% of Americans. Moreover, high myopia is associated with potentially blinding complications, such as glaucoma, retinal detachment, and myopic macular degeneration.
However, as the impact of the COVID-19 pandemic has been higher in this region, a significant proportion of elective surgeries were postponed as hospitals were converted into emergency units. Due to this, the intraocular lens regional market was expected to register a significant short-term impact due to the pandemic.
To understand geography trends, Download Sample Report
Companies are focusing on surgical advancements for ophthalmic disorders at reasonable costs. Major manufacturers of intraocular lenses are investing in mergers and acquisitions in order to expand revenue share and diversify product portfolios. Thus, the growing focus of companies in emerging countries and the gradual shift toward new technologies are offering significant growth opportunities for players in the market. Some of the major market players include Alcon, Hoya Corporation, Carl Zeiss MediTech AG, Bausch Health Companies Inc., and EyeKon Medical Inc.
In January 2022, Rayner, the only UK-based manufacturer of intraocular lenses, announced the expansion of its RayOne product portfolio, with the first blue light-filtering intraocular lens RayOne Hydrophobic BLF, to protect the retina from harmful blue light as well as reduce the risks of age-related macular degeneration in pseudophakic eyes.
In July 2021, Johnson & Johnson Vision received approval from the US Food and Drug Administration for its Tecnis Synergy and Tecnis Synergy Toric II intraocular lenses.
In February 2021, the US Food and Drug Administration approved Johnson & Johnson Vision’s TECNIS EyhanceTM and TECNIS EyhanceTM Toric II intraocular lens for the treatment of cataract patients in the United States.
Table of Contents
1.1 Study Assumptions and Market Definition
1.2 Scope of the Study
2. RESEARCH METHODOLOGY
3. EXECUTIVE SUMMARY
4. MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Increasing Ophthalmic Issues and Eye Diseases
4.2.2 Increasing Cases of Cataract in the Diabetic Population
4.2.3 Rising Adoption of Advanced Premium IOLs
4.3 Market Restraints
4.3.1 High Cost of IOLs
4.3.2 Lack of Reimbursement Policies
4.4 Porter's Five Forces Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry
5. MARKET SEGMENTATION
5.1 By Product
5.1.1 Monofocal Intraocular Lens
5.1.2 Accommodative Intraocular Lens
5.1.3 Multifocal Intraocular Lens
5.1.4 Toric Intraocular Lens
5.2 By End User
5.2.2 Ambulatory Centers
5.2.3 Other End Users
5.3.1 North America
22.214.171.124 United States
126.96.36.199 United Kingdom
188.8.131.52 Rest of Europe
184.108.40.206 South korea
220.127.116.11 Rest of Asia-Pacific
5.3.4 Middle-East and Africa
18.104.22.168 South Africa
22.214.171.124 Rest of Middle-East and Africa
5.3.5 South America
126.96.36.199 Rest of South America
6. COMPETITIVE LANDSCAPE
*List Not Exhaustive
6.1 Company Profiles
6.1.1 Alcon Inc.
6.1.2 Bausch Health Companies Inc.
6.1.3 Carl Zeiss Meditec AG
6.1.4 EyeKon Medical Inc.
6.1.5 Hoya Corporation
6.1.6 HumanOptics AG
6.1.7 Johnson and Johnson Vision Care Inc.
6.1.8 Lenstec Inc.
6.1.10 STAAR Surgical Company
7. MARKET OPPORTUNITIES AND FUTURE TRENDS
You can also purchase parts of this report. Do you want to check out a section wise price list?
Frequently Asked Questions
What is the study period of this market?
The Intraocular Lens Market market is studied from 2020 - 2027.
What is the growth rate of Intraocular Lens Market?
The Intraocular Lens Market is growing at a CAGR of 5.6% over the next 5 years.
Which region has highest growth rate in Intraocular Lens Market?
Asia-Pacific is growing at the highest CAGR over 2021- 2026.
Which region has largest share in Intraocular Lens Market?
North America holds highest share in 2021.
Who are the key players in Intraocular Lens Market?
HOYA Corporation, Alcon Inc., EyeKon Medical Inc., Carl Zeiss Meditec AG, Bausch Health Companies Inc. are the major companies operating in Intraocular Lens Market.